1W Return
1M Return
6M Return
1Y Return
3Y Return
Start SIP in Krebs Biochemicals & Industries Ltd
Stock Performance
52 Week Low - High
Today’s Low - High
Open
Prev. Close
Total Traded Value
Fundamental
Market Cap (in crs)
Face Value
Turnover (in lacs)
Key Metrics
Qtr Change %
52W Low on Mar 28, 2024
15.5
TTM PE Ratio
Negative PE TTM
-7.8
Price to Book Ratio
Negative Price to Book
-1.3
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is negative
-0.4
RSI
RSI is mid-range
52.2
MFI
MFI is mid-range
44.4
Krebs Biochemicals & Industries Ltd Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
Current Price
5Day EMA
71.20
10Day EMA
71.20
12Day EMA
71.10
20Day EMA
70.60
26Day EMA
70.20
50Day EMA
69.90
100Day EMA
70.60
200Day EMA
72.90
5Day SMA
71.00
10Day SMA
71.50
20Day SMA
70.20
30Day SMA
68.90
50Day SMA
69.60
100Day SMA
70.00
150Day SMA
72.80
200Day SMA
72.60
Resistance & Support
71.05
Pivot
Resistance
First Resistance
72.76
Second Resistance
74.58
Third Resistance
76.29
Support
First Support
69.23
Second support
67.52
Third Support
65.70
Relative Strength Index
52.21
Money Flow Index
44.39
MACD
0.82
MACD Signal
0.90
Average True Range
3.78
Average Directional Index
27.51
Rate of Change (21)
9.91
Rate of Change (125)
-10.47
Similar stocks
Similar Stocks
Peer comparison
Compare
| Company | Market Price | Market Cap | 52W Low | 52W High |
|---|---|---|---|---|
Mangalam Drugs and Organics Ltd. | 164.53 | 85.16 | 132.4 | |
Parnax Lab Ltd. | - | - | - | |
Aarey Drugs & Pharmaceuticals Ltd. | 120.3 | 30 | 68 | |
Auro Laboratories Ltd. | - | - | - | |
Sotac Pharmaceuticals Ltd | - | - | - | |
Medicamen Organics Ltd. | - | - | - |
Krebs Biochemicals & Industries Ltd Company background
Founded in: 1991
Managing director: Jitendra Shah
Krebs Biochemicals Industries Ltd (Formerly Krebs Biochemicals Ltd), promoted by R T Ravi in 1991 is engaged in the manufacture of Active Pharmaceutical Ingredients(API) through Fermentation process, one among very few in the world to do the same.Krebs develops commercially viable biotech processes for application in medicine, agriculture and industry. Undertaking contract manufacturing for large pharmaceutical and multinational companies and developing products for sale in global markets, the Company possesses expertise and infrastructure in chemical synthesis, fermentation and enzymatic technologies.KBIL which commenced commercial operations in the year 1994 with an installed capacity of 60 TPA has now grown to 150 TPA. KBL went to public with an IPO in 1994. During 200102, the company launched Vitamin C(I P Grade) through Fermentation Process. The Company commissioned 2.5 MW Cogeneration Power Plant at Unit II in Vizag during 200304 and started operations on it from July, 2004 onwards.
Krebs Biochemicals & Industries Ltd FAQs
How has Krebs Biochemicals & Industries Ltd [KREBSBIO] shares performed in the past ?
The past 1-year return of Krebs Biochemicals & Industries Ltd [KREBSBIO] share was -3.19. The Krebs Biochemicals & Industries Ltd [KREBSBIO] share hit a 1-year low of Rs. 60 and a 1-year high of Rs. 93.2.
How can I buy Krebs Biochemicals & Industries Ltd shares?
You can easily buy Krebs Biochemicals & Industries Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
Open Demat Account
